Michael R Bishop

11PUBLICATIONS

77CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCourts and sentencing

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 24, 2026

Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis.

|Jun 11, 2026

Management of Bispecific Antibody Toxicities: A Focus on Multiple Myeloma.

|Jun 04, 2026

CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|May 11, 2026

Low-Strength Type I Interferon Signaling Promotes CAR T Cell Treatment Efficacy.

|May 05, 2026

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Jun 24, 2025

Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.

Rakesh Awasthi, Stephan A Grupp, Edward R Waldron

Pageof 2

Frequent Collaborators

Joseph P McGurik

Stephen J Schuster

Richard T Maziarz

Peter A Riedell

Jamie Brower

Edmund K Waller

Miguel-Angel Perales

Olalekan O Oluwole

Jae H Park

Sairah Ahmed

Frequent Collaborators

Joseph P McGurik

Stephen J Schuster

Richard T Maziarz

Peter A Riedell